Filing Details
- Accession Number:
- 0001213900-16-012634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-18 17:27:28
- Reporting Period:
- 2016-04-14
- Filing Date:
- 2016-04-18
- Accepted Time:
- 2016-04-18 17:27:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388320 | Actinium Pharmaceuticals Inc. | ATNM | Pharmaceutical Preparations (2834) | 880378336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1522751 | J Kaushik Dave | C/O Actinium Pharmaceuticals, Inc 275 Madison Avenue, 7Th Floor New York NY 10016 | Ceo And Interim Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-14 | 8,000 | $2.02 | 86,500 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-04-14 | 2,000 | $2.01 | 88,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Acquisiton | 2016-04-15 | 400,000 | $1.99 | 400,000 | $1.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 400,000 | 2026-04-15 | No | 4 | A | Direct |
Footnotes
- Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant.
Billionaire Hedge Funds
